ArticleEvaluation of Glycogen Phosphorylase Activity in A Sample of Iraqi Patients with Myocardial Infarction
ArticleEvaluation of Glycogen Phosphorylase Activity in A Sample of Iraqi Patients with Myocardial Infarction
ArticleEvaluation of Vimentin and Some Biochemical Parameters in the Blood of Acute Myocardial Infarction Patients
ArticleEvaluation of Vimentin and Some Biochemical Parameters in the Blood of Acute Myocardial Infarction Patients
ThesisStudy of the association between the -2518g/a polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in the Egyptian patients
ThesisStudy of the association between the -2518g/a polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in the Egyptian patients
ArticleGene polymorphism and some inflammatory biomarkers associated with coronary artery disease in Egyptian Population
ArticleGene polymorphism and some inflammatory biomarkers associated with coronary artery disease in Egyptian Population
ArticleParaoxonase 1 Q192R (A/G) Gene Polymorphism as possible risk factor for coronary heart diseases among Egyptians. Case-control study
ArticleParaoxonase 1 Q192R (A/G) Gene Polymorphism as possible risk factor for coronary heart diseases among Egyptians. Case-control study
ArticleEvaluation of Some Trace Elements and Serum Electrolytes in Patients with Acute Myocardial Infraction
ArticleEvaluation of Some Trace Elements and Serum Electrolytes in Patients with Acute Myocardial Infraction
ArticleMicroRNA-499 Gene Expression in Egyptian Type 2 Diabetes Mellitus Patients with and without Coronary Heart Disease.
ArticleMicroRNA-499 Gene Expression in Egyptian Type 2 Diabetes Mellitus Patients with and without Coronary Heart Disease.
ArticleAssociation study of uncoupling protein 2-866G/A (rs659366) gene polymorphism and serum myeloperoxidase with cardiovascular disease in type 2 diabetic patients
ArticleAssociation study of uncoupling protein 2-866G/A (rs659366) gene polymorphism and serum myeloperoxidase with cardiovascular disease in type 2 diabetic patients